tiprankstipranks
Kuros Biosciences Ltd. (CSBTF)
OTHER OTC:CSBTF
US Market
CSBTF
Kuros Biosciences
RESEARCH TOOLSreports

Kuros Biosciences (CSBTF) Ratios

15 Followers

Kuros Biosciences Ratios

CSBTF's free cash flow for Q2 2026 was CHF0.85. For the 2026 fiscal year, CSBTF's free cash flow was decreased by CHF and operating cash flow was CHF0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.87 1.96 2.14 2.06 2.49
Quick Ratio
 1.28 1.45 1.69 1.69 2.24
Cash Ratio
 0.22 0.47 0.84 1.08 1.91
Solvency Ratio
 0.21 0.12 -0.04 -0.74 -0.83
Operating Cash Flow Ratio
 >-0.01 -0.01 0.15 -0.67 -0.58
Short-Term Operating Cash Flow Coverage
 -0.18 -0.73 5.94 -15.30 -1.18
Net Current Asset Value
CHF 18.96MCHF 25.21MCHF 18.96MCHF 12.44MCHF 17.31M
Leverage Ratios
Debt-to-Assets Ratio
 0.09 0.04 0.02 0.03 0.02
Debt-to-Equity Ratio
 0.15 0.06 0.03 0.04 0.03
Debt-to-Capital Ratio
 0.13 0.06 0.03 0.04 0.03
Long-Term Debt-to-Capital Ratio
 0.04 0.04 0.05 0.00 0.00
Financial Leverage Ratio
 1.67 1.60 1.44 1.26 1.20
Debt Service Coverage Ratio
 2.86 9.74 -1.37 -9.45 -0.71
Interest Coverage Ratio
 4.43 24.04 -33.52 -70.92 -3.11
Debt to Market Cap
 <0.01 <0.01 <0.01 <0.01 0.12
Interest Debt Per Share
 0.33 0.11 0.05 0.06 0.18
Net Debt to EBITDA
 0.27 -1.16 27.93 1.76 2.51
Profitability Margins
Gross Profit Margin
85.28%86.39%82.10%71.31%59.87%
EBIT Margin
6.01%6.04%-4.23%-28.57%-64.91%
EBITDA Margin
8.33%8.35%-0.74%-20.37%-49.15%
Operating Profit Margin
6.01%6.04%-6.61%-39.30%-74.76%
Pretax Profit Margin
6.15%3.43%-4.43%-29.13%-88.91%
Net Profit Margin
5.13%1.75%-4.92%-40.90%-81.15%
Continuous Operations Profit Margin
5.09%1.69%-4.92%-30.26%-81.15%
Net Income Per EBT
83.46%50.87%111.06%140.42%91.27%
EBT Per EBIT
102.31%56.84%66.99%74.11%118.93%
Return on Assets (ROA)
5.92%1.98%-4.40%-19.21%-17.60%
Return on Equity (ROE)
10.24%3.17%-6.33%-24.20%-21.20%
Return on Capital Employed (ROCE)
9.89%9.93%-7.85%-22.64%-19.11%
Return on Invested Capital (ROIC)
8.03%4.80%-7.72%-22.20%-15.94%
Return on Tangible Assets
8.02%2.83%-7.42%-45.03%-42.65%
Earnings Yield
0.99%0.20%-0.47%-10.75%-29.29%
Efficiency Ratios
Receivables Turnover
 3.87 3.81 5.06 4.41 4.97
Payables Turnover
 1.75 1.51 1.96 7.40 5.54
Inventory Turnover
 0.96 0.98 1.43 1.98 2.28
Fixed Asset Turnover
 8.86 32.72 24.99 12.70 7.74
Asset Turnover
 1.15 1.13 0.89 0.47 0.22
Working Capital Turnover Ratio
 4.38 4.34 3.99 2.05 0.89
Cash Conversion Cycle
 266.19 227.99 140.44 217.60 167.90
Days of Sales Outstanding
 94.34 95.83 72.14 82.83 73.42
Days of Inventory Outstanding
 380.07 374.11 254.86 184.09 160.32
Days of Payables Outstanding
 208.22 241.94 186.55 49.32 65.85
Operating Cycle
 474.41 469.93 326.99 266.93 233.74
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 0.08 -0.24 -0.22
Free Cash Flow Per Share
 -0.17 -0.06 0.05 -0.25 -0.23
CapEx Per Share
 0.16 0.05 0.03 <0.01 0.01
Free Cash Flow to Operating Cash Flow
 22.58 6.36 0.65 1.04 1.05
Dividend Paid and CapEx Coverage Ratio
 -0.05 -0.19 2.82 -27.13 -18.37
Capital Expenditure Coverage Ratio
 -0.05 -0.19 2.82 -27.13 -18.37
Operating Cash Flow Coverage Ratio
 -0.03 -0.10 1.75 -4.13 -3.84
Operating Cash Flow to Sales Ratio
 >-0.01 >-0.01 0.04 -0.26 -0.41
Free Cash Flow Yield
-0.92%-0.23%0.26%-7.18%-15.55%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 100.66 498.73 -213.71 -9.30 -3.41
Price-to-Sales (P/S) Ratio
 5.18 8.71 10.51 3.80 2.77
Price-to-Book (P/B) Ratio
 9.99 15.78 13.52 2.25 0.72
Price-to-Free Cash Flow (P/FCF) Ratio
 -108.66 -439.50 391.61 -13.92 -6.43
Price-to-Operating Cash Flow Ratio
 -2.45K -2.80K 252.93 -14.44 -6.78
Price-to-Earnings Growth (PEG) Ratio
 0.12 -3.21 2.90 0.80 -0.04
Price-to-Fair Value
 9.99 15.78 13.52 2.25 0.72
Enterprise Value Multiple
 62.47 103.14 -1.39K -16.91 -3.13
Enterprise Value
 721.74M 1.04B 778.52M 115.61M 27.68M
EV to EBITDA
 62.47 103.14 -1.39K -16.91 -3.13
EV to Sales
 5.20 8.61 10.30 3.44 1.54
EV to Free Cash Flow
 -109.14 -434.62 383.89 -12.61 -3.57
EV to Operating Cash Flow
 -2.46K -2.76K 247.94 -13.07 -3.77
Tangible Book Value Per Share
 1.03 0.90 0.65 0.43 0.59
Shareholders’ Equity Per Share
 1.82 1.74 1.58 1.55 2.03
Tax and Other Ratios
Effective Tax Rate
 0.17 0.51 -0.11 -0.04 0.09
Revenue Per Share
 3.52 3.16 2.03 0.92 0.53
Net Income Per Share
 0.18 0.06 -0.10 -0.38 -0.43
Tax Burden
 0.83 0.51 1.11 1.40 0.91
Interest Burden
 1.02 0.57 1.05 1.02 1.37
Research & Development to Revenue
 0.08 0.07 0.09 0.06 0.29
SG&A to Revenue
 0.72 0.67 0.55 0.25 0.17
Stock-Based Compensation to Revenue
 0.00 0.03 0.07 0.03 0.06
Income Quality
 -0.04 -0.07 -0.80 0.64 0.46
Currency in CHF